News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research Report>C Suisse Trims HUTCHMED (00013.HK) TP to $35.65, Rating Outperform
Credit Suisse maintained the FY22 topline expectations on HUTCHMED (00013.HK) unchanged, with slightly lower distribution revenue forecasts and higher oncology revenue estimates. T...
Reset
Send
The window will close in 5 seconds
<Research Report>C Suisse Trims HUTCHMED (00013.HK) TP to $35.65, Rating Outperform
Close
Recommend
13
Positive
24
Negative
9
 
SHORT SELL
 
STOCK INFO

Credit Suisse maintained the FY22 topline expectations on HUTCHMED (00013.HK)  -1.700 (-5.090%)    Short selling $5.84M; Ratio 3.523%   unchanged, with slightly lower distribution revenue forecasts and higher oncology revenue estimates. The broker raised the FY22/23/24 LPS assumption by 23% each, given its revised recurring non-controlling interest estimates.

HUTCHMED was rated at Outperform, with target price cut from $38.75 to $35.65.

The firm's distribution business could be prone to Shanghai's Covid lockdowns in 2Q22. Hence, the broker chopped the firm's FY22 distribution revenue growth forecast from 7% YoY to 4.5% YoY.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-05-17 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.